Epidemiology of Vector Born Diseases 3.0

Dear Colleagues,

This Special Issue is the continuation of our 2022 Special Issue “Epidemiology of Vector Born Diseases 2.0”.

Vector-borne infectious diseases, occuring due to parasites (malaria, leishmaniasis, trypanosomiasis, filariasis, etc.), viruses (chikungunya, dengue, phlebovirus, etc.) or bacteria (bartonellosis, Lyme disease), represent a significant fraction of the global infectious disease burden; indeed, nearly half of the world’s population is infected with at least one type of vector-borne pathogen. An understanding of the molecular basis of interactions between these pathogens and their hosts (vertebrate and invertebrate) would provide a rationale for developing new tools that aim at interrupting the transmission process and/or control infection.

The goal of this proposed Special Issue, entitled “Epidemiology of Vector-Borne Diseases”, is to present recent advances in the knowledge regarding etiology, pathogenesis, and transmission processes and its translation into tools for detecting and combating these diseases. Original articles, reviews, viewpoints, and perspectives focusing on new technological developments and breakthroughs in vector-borne diseases are welcome. Potential topics include, but are not limited to, the biochemistry and molecular biology of pathogens, vectors and their interactions; the application of new technology to vector-borne disease diagnosis; novel approaches for blocking disease transmission; studies on the determinants of vectorial competence and prevalence of infections in the field; microbiological or metagenomic analyses of microbiomes associated with vectors, their interaction with pathogens, vaccines, drug development, and drug resistance.

Manuscripts dealing with systemic review will only be acceptable in rare cases.

Dr. Denis Sereno
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• vector-borne infectious diseases
• malaria
• leishmaniasis
• trypanosomiasis
• filariasis
• molecular basis of interactions
• pathogens
• vaccines
• drug development and resistance